Your donation of $100 will fund 1 day of a researcher's time. Donors who permit recognition will be named as Research Supporters on the AUSiMED website.
Donations received are used to develop a critically needed new breast cancer treatment. The treatment we are seeking is for women with breast cancer resistant to all forms of treatment and as a result they have no prospect of survival. In Australia 20% of breast cancer patients are in this group (almost 3,000 deaths in 2011).
Surviving breast cancer is particularly an issue for women with inherited BRCA1 or 2 mutated genes and the tumours tend to become resistant to all forms of treatment.
Angelina Jolie inherited a BRCA1 mutated gene. Her risk of getting breast cancer from this mutated gene was over 90%. Her risk of getting ovarian cancer was over 50%. Because women with this mutated gene tend to be resistant to all forms of treatment, Angelina, decided to have both her breasts and her ovaries removed to prevent getting breast and ovarian cancer.
Inherited BRCA1 and 2 mutated genes is a major issue for the Jewish community as 1 in 40 (2.5%) of Ashkenazi women worldwide carry the mutated genes which is 10 times more prevalent amongst Ashkenazi women than the rest of the population.
AUSiMED has identified an outstanding research team in Australia at the Walter and Eliza Hall Institute in Melbourne and at the Sheba Medical Centre in Tel Aviv.l..They both have exceptional track records of success. Together they have developed an exciting collaborative research project to find out how breast cancers can become resistant to treatments and to determine how to stop this resistance process. The project is so impressive that the Australian team have recently been awarded with two years of funding for the proposed project by the National Breast Cancer Foundation. As a result, AUSiMED is now seeking to raise funds for the Israeli team, so they can commence on the project.